Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

PYXS | Pyxis Oncology Inc

Index- P/E- EPS (ttm)-2.84 Insider Own30.91% Shs Outstand34.96M Perf Week0.54%
Market Cap81.16M Forward P/E- EPS next Y-1.74 Insider Trans0.04% Shs Float30.31M Perf Month-17.41%
Income-98.92M PEG- EPS next Q-0.52 Inst Own21.79% Short Float / Ratio3.00% / 4.71 Perf Quarter-23.55%
Sales0.00M P/S- EPS this Y44.36% Inst Trans-2.33% Short Interest0.91M Perf Half Y-46.06%
Book/sh3.69 P/B0.50 EPS next Y14.39% ROA-47.35% Target Price11.67 Perf Year-7.50%
Cash/sh3.29 P/C0.56 EPS next 5Y34.60% ROE-55.38% 52W Range1.10 - 6.92 Perf YTD38.06%
Dividend- P/FCF- EPS past 5Y- ROI-59.59% 52W High-73.27% Beta1.09
Dividend %- Quick Ratio16.18 Sales past 5Y0.00% Gross Margin- 52W Low68.18% ATR0.18
Employees75 Current Ratio16.18 Sales Q/Q- Oper. Margin0.00% RSI (14)41.96 Volatility7.84% 9.28%
OptionableYes Debt/Eq0.15 EPS Q/Q47.42% Profit Margin- Rel Volume0.30 Prev Close1.95
ShortableYes LT Debt/Eq0.14 EarningsAug 11 BMO Payout- Avg Volume193.26K Price1.85
Recom1.00 SMA20-7.80% SMA50-16.43% SMA200-23.55% Volume58,802 Change-5.13%
Date Action Analyst Rating Change Price Target Change
Sep-05-23Initiated RBC Capital Mkts Outperform $7
Nov-02-21Initiated Jefferies Buy $25
Nov-02-21Initiated Credit Suisse Outperform $19
Nov-02-21Initiated BofA Securities Neutral $16
Sep-27-23 09:18AM
Sep-14-23 05:03PM
Aug-31-23 04:01PM
Aug-23-23 08:35AM
Aug-11-23 07:00AM
04:01PM Loading…
Aug-01-23 04:01PM
Jun-30-23 05:00PM
May-30-23 08:30AM
May-24-23 06:45AM
May-11-23 07:00AM
Mar-31-23 05:00PM
Mar-30-23 02:16PM
Mar-22-23 06:45AM
Mar-16-23 07:30AM
Feb-13-23 08:00AM
04:45PM Loading…
Dec-23-22 04:45PM
Dec-01-22 06:45AM
Nov-01-22 06:30AM
Sep-30-22 05:00PM
Aug-15-22 07:00AM
Jul-12-22 06:45AM
Jun-28-22 06:35AM
Jun-21-22 10:40AM
May-19-22 06:35AM
May-13-22 08:03AM
May-07-22 10:34AM
Apr-27-22 06:35AM
Apr-13-22 06:35AM
Apr-08-22 01:05PM
Mar-29-22 11:00AM
06:35AM Loading…
Mar-22-22 06:35AM
Jan-10-22 11:17AM
Dec-15-21 08:00AM
Dec-09-21 08:30AM
Nov-15-21 07:15AM
Nov-10-21 08:00AM
Oct-08-21 03:31PM
Oct-07-21 10:24PM
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Connealy Pamela AnnCFO and COOSep 28Buy1.878,00014,960818,532Sep 28 04:32 PM
Connealy Pamela AnnCFO and COOSep 27Buy1.856,42611,868810,532Sep 27 06:36 PM
Wadhane JitendraChief Accounting OfficerSep 27Buy1.872,5004,675226,937Sep 27 06:37 PM
Connealy Pamela AnnCFO and COOSep 25Buy1.6712,00020,044804,106Sep 25 05:04 PM
Wadhane JitendraChief Accounting OfficerSep 25Buy1.775,0008,850224,437Sep 25 05:05 PM
Connealy Pamela AnnCFO and COOSep 22Buy1.745,0008,695792,106Sep 22 07:34 PM
Wadhane JitendraChief Accounting OfficerSep 22Buy1.742,5004,349219,437Sep 22 07:35 PM
Sullivan LaraPresident and CEOSep 18Sale2.108,54117,9362,403,882Sep 18 07:03 PM
Sullivan LaraPresident and CEOSep 14Sale2.251002252,412,423Sep 18 07:03 PM
Sullivan LaraPresident and CEOSep 13Sale2.273,0006,8162,597,265Sep 13 08:16 PM
Sullivan LaraPresident and CEOSep 12Sale2.254,91711,0712,600,265Sep 13 08:16 PM
Sullivan LaraPresident and CEOSep 11Sale2.2720,00045,4142,605,182Sep 13 08:16 PM
PFIZER INC10% OwnerMar 17Buy2.761,811,5944,999,9995,952,263Mar 21 06:07 PM